Dow Jones

38 686,32

1,51%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Insys Therapeutics, Inc. (INSY)
Insys Therapeutics, Inc. (INSY) Actualités

INSY

INSYS THERAPEUTICS, INC. (INSY)

Insys Therapeutics, Inc.

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSY

1 2 3 4 5 6 7 8 9 10 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
04/11/2019	12h08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INSY	Insys Therapeutics, Inc.
08/08/2019	23h19	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:INSY	Insys Therapeutics, Inc.
03/07/2019	12h00	GlobeNewswire Inc.	FDA Accepts New Drug Application for INSYS Therapeutics’ Naloxone Nasal Spray for the Emergency Treatment of Known or Suspe...	NASDAQ:INSY	Insys Therapeutics, Inc.
24/06/2019	15h38	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:INSY	Insys Therapeutics, Inc.
12/06/2019	14h00	GlobeNewswire Inc.	INSYS Therapeutics, Inc. Receives Court Approval of “First Day” Motions	NASDAQ:INSY	Insys Therapeutics, Inc.
10/06/2019	15h32	Dow Jones News	Stocks to Watch: Salesforce.com, Insys, United Technologies, Barnes & Noble, Dunkin' Brands, and More	NASDAQ:INSY	Insys Therapeutics, Inc.
10/06/2019	12h07	GlobeNewswire Inc.	INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities	NASDAQ:INSY	Insys Therapeutics, Inc.
07/06/2019	20h10	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:INSY	Insys Therapeutics, Inc.
06/06/2019	23h13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSY	Insys Therapeutics, Inc.
06/06/2019	23h11	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:INSY	Insys Therapeutics, Inc.
13/05/2019	12h02	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INSY	Insys Therapeutics, Inc.
11/05/2019	01h05	GlobeNewswire Inc.	INSYS Therapeutics Reports First Quarter 2019 Results	NASDAQ:INSY	Insys Therapeutics, Inc.
30/04/2019	22h24	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:INSY	Insys Therapeutics, Inc.
29/04/2019	18h38	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:INSY	Insys Therapeutics, Inc.
15/04/2019	14h30	GlobeNewswire Inc.	INSYS Therapeutics Implements Leadership Changes	NASDAQ:INSY	Insys Therapeutics, Inc.
08/04/2019	14h30	GlobeNewswire Inc.	Report: Exploring Fundamental Drivers Behind Zscaler, Golden Star Resources, Flexion Therapeutics, SP Plus, Insys Therapeutic...	NASDAQ:INSY	Insys Therapeutics, Inc.
25/03/2019	11h00	GlobeNewswire Inc.	INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Dru...	NASDAQ:INSY	Insys Therapeutics, Inc.
13/03/2019	11h08	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:INSY	Insys Therapeutics, Inc.
07/03/2019	22h15	GlobeNewswire Inc.	INSYS Therapeutics Reports Fourth Quarter and Full Year 2018 Results	NASDAQ:INSY	Insys Therapeutics, Inc.
06/03/2019	22h15	GlobeNewswire Inc.	INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7	NASDAQ:INSY	Insys Therapeutics, Inc.
25/02/2019	12h00	GlobeNewswire Inc.	INSYS Therapeutics Presented Poster of Initial Pharmacokinetic Study of Epinephrine Nasal Spray for the Emergency Treatment o...	NASDAQ:INSY	Insys Therapeutics, Inc.
19/02/2019	20h07	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:INSY	Insys Therapeutics, Inc.
09/01/2019	12h00	GlobeNewswire Inc.	INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatment of Anaphylaxis	NASDAQ:INSY	Insys Therapeutics, Inc.
03/01/2019	12h00	GlobeNewswire Inc.	INSYS Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference	NASDAQ:INSY	Insys Therapeutics, Inc.
18/12/2018	12h00	GlobeNewswire Inc.	INSYS Therapeutics Announces Participation at FDA Advisory Committee Meeting Addressing the Co-Prescribing of Naloxone	NASDAQ:INSY	Insys Therapeutics, Inc.
17/12/2018	12h00	GlobeNewswire Inc.	INSYS Therapeutics Provides Update on Strategic Alterative Review Process and Product Pipeline Spanning Pharmaceutical Cannab...	NASDAQ:INSY	Insys Therapeutics, Inc.
04/12/2018	12h00	GlobeNewswire Inc.	INSYS Therapeutics Presents New Clinical Data from Long-Term Safety Study of CBD Oral Solution in Refractory Pediatric Epile...	NASDAQ:INSY	Insys Therapeutics, Inc.
20/11/2018	13h00	GlobeNewswire Inc.	Clinical Data from Long-Term Safety-Study of Company’s Pharmaceutical CBD in Refractory Pediatric Epilepsy To Be Presented...	NASDAQ:INSY	Insys Therapeutics, Inc.
06/11/2018	14h45	InvestorWire	As the Cannabis Industry Grows, So Do Challenges of Supply and Distribution	NASDAQ:INSY	Insys Therapeutics, Inc.
05/11/2018	22h16	GlobeNewswire Inc.	INSYS Therapeutics Reports Third Quarter 2018 Results	NASDAQ:INSY	Insys Therapeutics, Inc.